Related Experiment Videos
Transcriptome profiling and the pathogenesis of diabetic complications.
Susan B Connolly1, Denise Sadlier, Niamh E Kieran
1Department of Medicine and Therapeutics, Mater Misericordiae University Hospital, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Ireland.
Journal of the American Society of Nephrology : JASN
|July 23, 2003
Summary
Diabetes complications like kidney failure are a growing global health issue. Transcriptomics offers new therapeutic targets by revealing molecular events driving diabetic nephropathy progression.
Area of Science:
- Endocrinology
- Molecular Biology
- Genomics
Background:
- Diabetes mellitus is a global health crisis, leading to severe complications such as vascular disease, renal failure, and blindness.
- High glucose levels trigger cellular injury via pathways including protein kinase C activation, aldose reductase flux, advanced glycosylation end products, and reactive oxygen species.
- Current treatments optimize glycemic control and blood pressure, utilizing ACE inhibitors, ARBs, and statins, but rarely halt disease progression.
Purpose of the Study:
- To review the potential of transcriptomics for identifying novel therapeutic targets in diabetic complications.
- To highlight recent advancements in understanding diabetic nephropathy pathogenesis through gene expression analysis.
Main Methods:
- Global monitoring of cellular or tissue mRNA expression (transcriptomics) was employed.
- Focus on recent studies investigating the molecular mechanisms of diabetic nephropathy.
Main Results:
- Transcriptomics provides a comprehensive view of molecular events underlying diabetic complications.
- Gene expression profiling reveals key pathways involved in the pathogenesis of diabetic nephropathy.
Conclusions:
- Transcriptomics holds significant promise for discovering new therapeutic strategies against diabetic complications.
- Elucidating molecular events through transcriptomics is crucial for developing effective treatments for diabetic nephropathy.